CONGRESS: 22–25 SEPTEMBER 2025
Source LDPath
Source LDPath Stand: 720 Source LDPath, a part of the Source BioScience group, provides flexible cellular and digital pathology services to the NHS and private healthcare. A market leader for histopathology services in the UK, Source LDPath supports NHS and private healthcare increase reporting capacities and clear backlogs of cellular and molecular diagnostic pathology samples. The company provides an end-to-end clinical healthcare service from histopathology, including digital pathology and AI, through to molecular diagnostics services, and hosts a significant and growing network of 280-plus specialist Consultant Pathologists.
The full range of diagnostic solutions will be showcased at Congress, with a focus this year on how digital pathology is accelerating the future of diagnostic reporting by improving workflow efficiency and enhancing patient care. The Source team will be available to discuss how the company’s integrated services can support pathology departments in managing increasing workloads and delivering faster results.
www.sourcebioscience.com
Stago
Stand: 619 This September, visit Stago at IBMS Congress to experience the future of
Sterilab Services
haemostasis diagnostics. From cutting- edge analysers to intelligent digital ecosystems, the firm is showcasing solutions that empower laboratories to work smarter, faster, and more accurately. Delegates can get hands-on with the sthemO 301 and sthemO 201 analysers, featuring dual-technology clot detection and intuitive design. Discover how the sthemE Manager, Expert QC, Qualiris and Accreditation tools elevate laboratory performance and quality assurance. Visitors to the stand can also take part in Stago’s interactive charity game and help raise funds for Surfers Against Sewage, a UK-based environmental charity tackling ocean pollution. At 5pm on the Tuesday and Wednesday, Champagne will be on offer to celebrate Stago’s 80th birthday
www.stago-uk.com
Sterilab Services Stand: 804
Sterilab Services is excited to return to the IBMS Congress, showcasing its most advanced portfolio to date, designed to meet the evolving needs of modern diagnostics and healthcare efficiency. Sterilab’s expanded point-of-care testing range now includes advanced urinalysis solutions, integrated IQC tools, and a rapid fungal detection test, a major step forward in real-time, frontline diagnostics. These enhancements support faster, more accurate clinical decisions in urgent care environments. As an official Copan
Stago
WWW.PATHOLOGYINPRACTICE.COM SEPTEMBER 2025
partner, the company is excited to spotlight the full range of liquid-based microbiology and swab collection systems. With pre-analytical integrity under increasing scrutiny, Sterilab’s Copan offering ensures high-quality, reliable sampling for laboratories nationwide. In respiratory
diagnostics Sterilab’s connected digital rapid test for FLU A/B, COVID & RSV has delivered outstanding results across NHS Trusts, helping to reduce winter pressures by supporting faster diagnosis and smarter bed management. Offering improved patient flow, fewer unnecessary admissions, and more efficient use of resources. Sterilab continues to invest in technology that empowers laboratory professionals and improves clinical outcomes.
www.sterilab.co.uk
Sysmex UK Stand: 215 Sysmex UK is proud to be a Principal Sponsor exhibiting at IBMS Congress. Delegates can visit the firm to explore how its innovations in intelligent automation and smartly linked diagnostic pathways are helping transform the healthcare journey. This year’s stand will bring to life the theme of smartly linked healthcare intelligence, reflecting Sysmex’s commitment to supporting clinicians and laboratories from screening and diagnosis
Sysmex UK 69
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84
